Iktos has a strong expertise in deep learning-based de novo design for medicinal chemistry: superior technology, experience and skills, and technical infrastructure. In a relatively short time frame, we provide solutions that help to accelerate your research projects, from hit discovery to lead optimization, using ligand-based or structure-based approaches.

Your libraries and assays, our technology… to discover exciting and innovative compounds – deal terms to be discussed on a case-by-case basis.

We have developed Makya a SaaS application for AI-driven de novo design . We have also released Spaya, our computer-aided synthetic planning technology freely available here. If you are interested in assessing synthetic feasibility of thousands or even millions of molecules, contact us to try Spaya API.